Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1

While there is considerable genetic and pathologic evidence for an association between neuregulin 1 (NRG1) dysregulation and schizophrenia, the underlying molecular and cellular mechanisms remain unclear. Mutant mice containing disruption of the transmembrane (TM) domain of the NRG1 gene constitute...

Full description

Bibliographic Details
Main Authors: O'Tuathaigh, C.M.P., Mathur, N., O'Callaghan, M.J., MacIntyre, L., Harvey, R., Lai, D., Waddington, J.L., Pickard, B.S., Watson, D.G., Moran, Paula M.
Format: Article
Published: Oxford University Press 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/39462/
_version_ 1848795842173992960
author O'Tuathaigh, C.M.P.
Mathur, N.
O'Callaghan, M.J.
MacIntyre, L.
Harvey, R.
Lai, D.
Waddington, J.L.
Pickard, B.S.
Watson, D.G.
Moran, Paula M.
author_facet O'Tuathaigh, C.M.P.
Mathur, N.
O'Callaghan, M.J.
MacIntyre, L.
Harvey, R.
Lai, D.
Waddington, J.L.
Pickard, B.S.
Watson, D.G.
Moran, Paula M.
author_sort O'Tuathaigh, C.M.P.
building Nottingham Research Data Repository
collection Online Access
description While there is considerable genetic and pathologic evidence for an association between neuregulin 1 (NRG1) dysregulation and schizophrenia, the underlying molecular and cellular mechanisms remain unclear. Mutant mice containing disruption of the transmembrane (TM) domain of the NRG1 gene constitute a heuristic model for dysregulation of NRG1-ErbB4 signalling in schizophrenia. The present study focused on specialised behavioural and characterisation of hitherto un-characterised information processing phenotypes in this mutant line. Using a mass spectrometry-based metabolomics approach, we also quantified levels of unique metabolites in brain. Across two different sites and protocols, Nrg1 mutants demonstrated deficits in pre-pulse inhibition, a measure of sensorimotor gating that is disrupted in schizophrenia; these deficits were partially reversed by acute treatment with second-, but not first-, generation antipsychotic drugs. However, Nrg1 mutants did not show a specific deficit in latent inhibition, a measure of selective attention that is also disrupted in schizophrenia. In contrast, in the ‘what-where-when’ cognitive paradigm, Nrg1 mutants displayed sex-specific (males only) disruption of ‘what-when’ performance, indicative of impaired episodic memory. Differential metabolomic profiling revealed that these behavioural phenotypes were accompanied, most prominently, by alterations in lipid metabolism pathways. This study is the first to associate these novel physiological mechanisms, previously independently identified as being abnormal in schizophrenia, with disruption of NRG1 function. These data suggest novel mechanisms by which compromised neuregulin function from birth might lead to schizophrenia-relevant behavioural changes in adulthood.
first_indexed 2025-11-14T19:38:30Z
format Article
id nottingham-39462
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:38:30Z
publishDate 2017
publisher Oxford University Press
recordtype eprints
repository_type Digital Repository
spelling nottingham-394622020-05-04T18:37:17Z https://eprints.nottingham.ac.uk/39462/ Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1 O'Tuathaigh, C.M.P. Mathur, N. O'Callaghan, M.J. MacIntyre, L. Harvey, R. Lai, D. Waddington, J.L. Pickard, B.S. Watson, D.G. Moran, Paula M. While there is considerable genetic and pathologic evidence for an association between neuregulin 1 (NRG1) dysregulation and schizophrenia, the underlying molecular and cellular mechanisms remain unclear. Mutant mice containing disruption of the transmembrane (TM) domain of the NRG1 gene constitute a heuristic model for dysregulation of NRG1-ErbB4 signalling in schizophrenia. The present study focused on specialised behavioural and characterisation of hitherto un-characterised information processing phenotypes in this mutant line. Using a mass spectrometry-based metabolomics approach, we also quantified levels of unique metabolites in brain. Across two different sites and protocols, Nrg1 mutants demonstrated deficits in pre-pulse inhibition, a measure of sensorimotor gating that is disrupted in schizophrenia; these deficits were partially reversed by acute treatment with second-, but not first-, generation antipsychotic drugs. However, Nrg1 mutants did not show a specific deficit in latent inhibition, a measure of selective attention that is also disrupted in schizophrenia. In contrast, in the ‘what-where-when’ cognitive paradigm, Nrg1 mutants displayed sex-specific (males only) disruption of ‘what-when’ performance, indicative of impaired episodic memory. Differential metabolomic profiling revealed that these behavioural phenotypes were accompanied, most prominently, by alterations in lipid metabolism pathways. This study is the first to associate these novel physiological mechanisms, previously independently identified as being abnormal in schizophrenia, with disruption of NRG1 function. These data suggest novel mechanisms by which compromised neuregulin function from birth might lead to schizophrenia-relevant behavioural changes in adulthood. Oxford University Press 2017-03-11 Article PeerReviewed O'Tuathaigh, C.M.P., Mathur, N., O'Callaghan, M.J., MacIntyre, L., Harvey, R., Lai, D., Waddington, J.L., Pickard, B.S., Watson, D.G. and Moran, Paula M. (2017) Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1. Schizophrenia Bulletin . ISSN 1745-1701 Mutant Phenotype Cognition Metabolome Antipsychotics Neuregulin Pre-pulse inhibition Choline Lipids Schizophrenia https://academic.oup.com/schizophreniabulletin/article-lookup/doi/10.1093/schbul/sbw189 doi:10.1093/schbul/sbw189 doi:10.1093/schbul/sbw189
spellingShingle Mutant Phenotype
Cognition
Metabolome
Antipsychotics
Neuregulin
Pre-pulse inhibition
Choline
Lipids
Schizophrenia
O'Tuathaigh, C.M.P.
Mathur, N.
O'Callaghan, M.J.
MacIntyre, L.
Harvey, R.
Lai, D.
Waddington, J.L.
Pickard, B.S.
Watson, D.G.
Moran, Paula M.
Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title_full Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title_fullStr Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title_full_unstemmed Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title_short Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
title_sort specialised information processing deficits and distinct metabolomics profiles following tm-domain disruption of nrg1
topic Mutant Phenotype
Cognition
Metabolome
Antipsychotics
Neuregulin
Pre-pulse inhibition
Choline
Lipids
Schizophrenia
url https://eprints.nottingham.ac.uk/39462/
https://eprints.nottingham.ac.uk/39462/
https://eprints.nottingham.ac.uk/39462/